Xiaodong Wang
a,
Lu An
*a,
Qiwei Tian
*a and
Kuili Cui
b
aThe Key Laboratory of Resource Chemistry of the Ministry of Education, The Shanghai Key Laboratory of Rare Earth Functional Materials, The Shanghai Municipal Education Committee Key Laboratory of Molecular Imaging Probes and Sensors, Shanghai Normal University, Shanghai, 200234, China. E-mail: qiweitian@shnu.edu.cn; anlu1987@shnu.edu.cn
bDepartment of Tuberculosis, The First Affiliated Hospital of Xinxiang Medical University, China
First published on 18th October 2019
Hydrogen sulfide (H2S) is a key biosignal molecule in the human body. Endogenous H2S, as a gas delivery and protective agent in the body, is involved in a variety of physiological processes, including mediating vascular tone and neuromodulation. The production of abnormal H2S levels in the body is related to the occurrence of various diseases, so real-time monitoring of H2S in vivo is very important. However, traditional detection methods face enormous challenges in the in vivo detection of H2S owing to its high volatility and rapid catabolism. Optical probes developed in recent years with the advantages of high sensitivity, short response time, non-invasive nature and capacity for real-time monitoring can overcome the limitations of traditional detection methods and offer the possibility of real-time monitoring of H2S in cells and in vivo. In addition, the production of high concentrations of H2S is closely related to the formation of colon cancer, and H2S-activated treatment agents have been developed for use in this particular tumor microenvironment, which reduce the toxic side effects of traditional therapy on normal tissues and improves the treatment effect. This review summarizes the recent advances in H2S detection probes in vitro and in vivo, as well as H2S-activated tumor treatment agents.
Traditional analytical methods for H2S mainly include colorimetry,21 electrochemical analysis,22 gas chromatography,23 and sulfide precipitation.24 These methods need high-standard preparation of samples and collection of H2S from cells or tissues.25–27 However, a fast H2S catabolism rate leads to fluctuations in its concentration, further resulting in inaccurate measurement.28,29 Therefore, the traditional methods have difficulty meeting fast, accurate, and real-time monitoring criteria for H2S levels in living systems. Optical detection methods are attracting increasing research interest owing to their high sensitivity, short response time, non-invasive nature, capacity for real-time monitoring and easy sample preparation.30–33 Based on the good nucleophilic and reducing chemistry of H2S, researchers have been developing optical probes with high sensitivity, selectivity and biocompatibility for the detection of H2S in biological systems. These probes are based primarily on specific H2S-induced reactions, including azide reduction,34–36 nitro reduction,37,38 removal of quenchers (such as copper(II)),39–41 and nucleophilic reactions,42–44 to allow fluorescence to be turned on for H2S detection at different biological levels.
In addition, there have been some reports that CBS is selectively up-regulated and the concentration of H2S is significantly increased in cancer tissues such as colon, breast and ovarian cancers.45–48 H2S plays an important role in tumor proliferation and metastasis, and has become a new target for cancer treatment.49 Traditional cancer treatment methods mainly include surgical resection, chemotherapy, radiotherapy and other means.50–52 These treatment methods not only have a low cure rate, but also have relatively large side effects.53 Scientists are working to develop H2S-activated reagents for the treatment of cancer, on account of high concentrations of H2S in the tumor microenvironment. These mainly include: (i) H2S-activated nanodrug carriers for delivering chemotherapeutic drugs to tumor sites, improving the therapeutic efficiency of cancer while reducing the toxic side effects on normal tissues;54 (ii) H2S trapped in normal tissues after intravenous injection, causing damage to normal tissues on light irradiation. The H2S-activated phototherapy agent only produces therapeutic effects at the tumor site, thereby reducing damage to normal tissues.
In this review, we summarize the recent developments of H2S-activated probes in the biomedical field, including fluorescent probes and photoacoustic probes for in vitro and in vivo applications. In addition, the application and advantages of H2S-activated reagents in cancer diagnosis and treatment are also discussed. We also reference the side effects of traditional therapy reagents in the treatment of tumors, and describe the requirements and challenges of H2S-activated reagents. Finally, the possible future application prospects of H2S-activated diagnostic and therapeutic reagents for cancer therapy are also discussed.
H2S probe | Reaction mechanism | Wavelength (nm) | Detection limit | Experimental subject | Detection method | Ref. |
---|---|---|---|---|---|---|
Cyclen-AF + Cu2+ (HSip-1) | Cu2+ quenches fluorescence | 516 | 10 μM | HeLa cells | Fluorescence microscopy | 69 |
SHS-M2 | Azides to amines | 464/545 | 0.4 μM | DJ-1 deficient astrocytes and brain slices | Two-photon microscopy | 71 |
NanoBODIPY | Nucleophilic reactions | 511/589 | 7 nM | Raw 264.7 macrophage cells | Confocal microscopy | 76 |
Coumarin–merocyanine dyad (CPC) | Nucleophilic reactions | 474/587 | 40 nM | HeLa cells | Confocal microscopy | 77 |
Azide-functionalized O-methylrhodol (MeRho-Az) | Azides to amines | 516 | 86 ± 7 nM | C6 cells and zebrafish | Light sheet fluorescence microscopy | 80 |
Ruthenium(II) complex-based luminescence probe (Ru-MDB) | Nucleophilic reactions | 456/612 | 45 nM | Zebrafish and mice | Fluorescence microscopy and confocal microscopy | 83 |
NIR-II@Si | Nucleophilic reactions | 700/900 | 37 nM | HCT116 tumor mice | Fluorescence imaging | 85 |
Si@BODPA | Nucleophilic reactions | 780 | 53 nM | HCT116 tumor mice | Photoacoustic imaging | 88 |
AzHD-LP | Azides to amines | 600/700 | 91 nM | HCT116 tumor mice | Photoacoustic imaging | 89 |
Based on the nucleophilic and reductive properties of H2S, scientists have developed fluorescent probes for H2S detection founded on the reduction of azides to amines, nucleophilic reactions and copper sulfide precipitation.63–66 Liu et al.67 designed a H2S fluorescent probe containing bis-electrophile to take advantage the nucleophilicity of H2S. The fluorescence intensity of the disulfide-containing probe increased dramatically (55–70-fold) when 50 μM H2S was presented in solution. In addition, the maximum intensity was reached in 1 h, suggesting that the reaction was fast. The fluorescent probe is selective for H2S and does not react with other bio-thiols, such as cysteine and glutathione, at the same concentration (100 μM). A fluorophore of dansyl azide (DNS-Az) with high quantum yield was prepared by Peng et al.68 The azide is reduced to an amine by reduction with H2S to emit fluorescence for rapid detection of H2S in vitro. The probe was very sensitive, with a detection limit of 1 μM in buffer/Tween and 5 μM in bovine serum. The reaction was complete in a few seconds, while the fluorescence was enhanced immediately. No obvious response to the probe was observed for most of the tested anions at a concentration of 1 mM, which is a 40-fold higher concentration than that of sulfide. Sasakura et al.69 designed and synthesized a novel H2S-detecting fluorescent probe Cyclen-AF + Cu2+ (HSip-1) based on the azamacrocyclic ring to form a stable metal complex with Cu2+. The paramagnetic Cu2+ center could quench the fluorophore's fluorescence. When H2S binds to Cu2+, Cu2+ is released from the azamacrocyclic ring, resulting in enhanced fluorescence. The probe showed a large (50-fold) and immediate increase in the fluorescence intensity upon addition of 10 μM H2S, whereas almost no fluorescence increment was observed upon the addition of 10 mM GSH. Thus, HSip-1 is more selective for H2S than previously reported fluorescent probes using 2,4-dinitrosulfonyl or azide groups.
For most single-window-response fluorescent probes the experimental results change with the experimental conditions.70 Ratiometric fluorescent probes are able to overcome the interference due to experimental conditions. Bae et al.71 reported a H2S-activated mitochondrially localized two-photon ratiometric fluorescent probe, SHS-M2 (Fig. 1A), which has 6-(benzo[d]thiazol-2-yl)-2-(methylamino) naphthalene as the fluorophore, 4-azidobenzyl carbamate as the H2S response site, and triphenylphosphonium salt as the mitochondria-targeting moiety. The thiolate-triggered reaction with the azide group would cleave the carbamate linkage and liberate the amino group, accompanied by a decrease in emission intensity at 420 nm and a gradual increase at 500 nm. The color also changes from blue to yellow. Thereby, the emission and the cross-section of the ratiometric two-photon probe can be increased (Fig. 1B). The probe is more sensitive and the detection limit of H2S is 0.4 μM in vitro. The fluorescence intensity of the SHS-M2 after triggering by H2S (0.1 mM) is 5–8-fold higher than that with 10 mM glutathione (GSH) and 1 mM cysteine (Cys), which confirms the high selectivity for H2S over GSH and Cys. Two-photon microscopy ratiometric imaging of SHS-M2 as a probe can be used to study the relationship between CBS expression and H2S levels in cells and brain sections (Fig. 1C).
Fig. 1 (A) The structure of SHS-M2. (B) Fluorescence response of 1 μM SHS-M2 to 100 μM Na2S in HEPES buffer from 0 to 60 min. λex = 373 nm. (C) The relationship between CBS expression and H2S production in astrocytes of DJ-1 knockout (KO) brain. Brain slices were prepared from wild-type (WT) and DJ-1 KO mice. (1) Hippocampal slices were prepared and stained for GFAP (an astrocyte marker) and CBS-expressed H2S; (2) H2S analysis of freshly prepared slices; (3) cortical slices were cultured for 7 days after slicing to stabilize the tissues from slicing stress, and then the H2S production was measured. Reproduced from ref. 71. Copyright 2013 American Chemical Society. |
The main problem of current H2S probes is low detection sensitivity. Förster resonance energy transfer (FRET)-based fluorescent probes can eliminate the effect of excitation backscattering on fluorescence detection because of the large offset between donor excitation and acceptor emission.72,73 In addition, two well-separated emission bands with comparable intensities can be used to ensure the accuracy of their strength and ratio. Some fast and accurate ratiometric fluorescent probes for detecting H2S have been developed based on FRET.74,75 Zhao et al.76 developed a self-assembled micelle aggregate NanoBODIPY fluorescent probe with H2S-triggered FRET switch, which consists of a dynamic energy receptor semi-cyanine-BODIPY hybrid dye (BODInD-Cl) and a complementary energy donor (BODIPY1). In the absence of H2S, a specific FRET from BODIPY1 to BODInD-Cl occurs due to the spectral overlap between the emission spectrum of the donor and the absorption spectrum of the acceptor. In contrast, in the presence of H2S, the Cl on the aromatic ring in NanoBODIPY is replaced by the H2S via nucleophilic substitution and the absorption of the probe is shifted from 540 to 738 nm, resulting in loss of FRET owing to the lack of overlap between the emission spectrum of the donor and the absorption spectrum of the acceptor (Fig. 2A). This results in a fluorescence signal that simultaneously “turns on” the energy donor BODIPY1 and a fluorescence signal that “closes” the energy acceptor BODInD-Cl. NanoBODIPY can sensitively and quickly detect H2S with a detection limit of 7 nM by ratiometric fluorescence. The emission intensity gradually increased at 511 nm after adding different concentrations of sodium hydrosulfide (NaHS), accompanied by a loss of emission at 589 nm, and the response was complete within 140 s (Fig. 2B). Through competitive experimental studies, NanoBODIPY showed good selectivity for NaHS with minimal interference from other biologically relevant analytes in PBS buffer (Fig. 2C).
Fig. 2 (A) The structure of NanoBODIPY and the FRET process from the complementary energy donor (BODIPY1) to the responsive energy acceptor BODInD-Cl. (B) Change in ratiometric fluorescence intensity of NanoBODIPY in the presence of NaHS (100 μM) at different times and fluorescence spectra in various concentrations of NaHS (0, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, 8.5, 9.0, 9.5, 10.0 μM, respectively). (C) Ratiometric fluorescence changes of NanoBODIPY in the presence of 100 μM NaHS and other biologically relevant competing analytes. λex = 490 nm. Reproduced from ref. 76. Copyright 2015 American Chemical Society. |
By a similar approach, Feng et al.77 reported a FRET-based ratiometric fluorescent probe composed of a coumarin–merocyanine dyad. Before the reaction with H2S, the emission wavelength of coumarin apparently overlaps with the absorption of merocyanine, and a resonance energy transfer process occurs, so that the probe displays the fluorescence of the cyanine. In the presence of H2S, the merocyanine moiety undergoes a nucleophilic addition reaction with H2S, and the conjugated system is destroyed; as a result, resonance energy transfer cannot be achieved, and so the fluorescence of coumarin is exhibited. The probe has a detection limit of as low as 40 nM. It can be used for mitochondrial endogenous and exogenous H2S detection; it shows a greater emission shift than other H2S probes, and so it exhibits higher selectivity and sensitivity.
Fig. 3 (A) Schematic of 3D imaging in live zebrafish using light sheet fluorescence microscopy. (B) Uncorrected fluorescence spectra response of 5 μM MeRho-Az to 250 μM NaHS treatment over 60 min. λex = 476 nm, λem = 480–650 nm. (C) Fluorescence intensity of MeRho-Az in the presence of various concentrations of NaHS for 90 min. (D) Fluorescence imaging of H2S in C6 cells treated with (1) MeRho-Az probe, (2) AP39 (H2S donor) and (3) AOAA (H2S inhibitor) respectively. Reproduced from ref. 80. Copyright 2015 American Chemical Society. |
Phosphorescent transition metal complexes have attracted much attention owing to their strong visible light absorption and emission, large Stokes shift, and stable photochemical properties.81,82 A ruthenium(II) complex-based responsive luminescence probe (Ru-MDB) for H2S detection was studied by Du et al.83 MBD is a masking moiety for the Ru-MDB complex H2S response. The metal-to-ligand charge transfer (MLCT) excited state of the RuII complex is destroyed by an intramolecular light-induced electron transfer photo-induced electron transfer (PET) process when the electron acceptor group MDB is linked (Fig. 4A). To utilize the nucleophilic properties of H2S, the new MDB masking group was linked to one of the bipyridine ligands of the RuII complex through an ester bond that could be cleaved by H2S, resulting in an approximately 86-fold increase in luminescence intensity. The detection limit was measured to be 45 nM, which suggested high sensitivity of Ru-MDB for monitoring H2S in mice. The main characteristics of this probe enabled the monitoring of lysosomal H2S generation in live cells, and the visualization of exogenous/endogenous H2S in live Daphnia magna, zebrafish and mice (Fig. 4B).
Fig. 4 (A) Strategy for the design and phosphorescence response mechanism with H2S of Ru-MDB, and the application of Ru-MDB in quantitative monitoring and visualizing of H2S in vitro and in vivo. (B) Luminescence imaging of H2S in live mice using Ru-MDB as a probe, and time-dependent increments of mean luminescence intensities. One group had Ru-MDB subcutaneously injected into the left and right hindlegs, followed by the injection of H2S into the left hindleg and the imaging of the mice at different times. In the other two groups, cysteine (Cys) and lipopolysaccharide (LPS), respectively, were injected into the right hindleg, and then Ru-MDB was injected into the left and right hindlegs. Reproduced from ref. 83. Copyright 2018 WILEY-VCH. |
Fluorescence imaging in the second near-infrared window (NIR-II, 1000–1700 nm) showed reduced autofluorescence, enhanced tissue penetration, and higher spatial resolution in vivo.84 Xu et al.85 designed a H2S-activated NIR-II@Si fluorescent probe (Fig. 5A) that visualizes colorectal cancer. The probe encapsulates the H2S-responsive fluorescent probe in the hydrophobic interior of the core–shell silica nanocomposite. The fluorescent nanoprobes comprise two organic chromophores: boron-dipyrromethene (ZX-NIR) dye, which has a maximum emission shift from 600 nm to 900 nm in the presence of H2S to produce NIR-II emission, and aza-BODIPY (aza-BOD), the emission of which remains unchanged at 700 nm, as an internal reference (Fig. 5B and C).The detection limit for H2S was measured to be 37 nM, indicating the high sensitivity of NIR-II@Si for ratiometric detection of H2S. This activatable H2S-specific targeting probe can be used for deep tissue imaging of H2S-rich colon cancer cells. Utilizing the advantages of NIR-II imaging, tumor sites can be selectively detected, and visual monitoring of tumor models of colon cancer can be achieved (Fig. 5D).
Fig. 5 (A) Schematic of the construction of multi-wavelength nanoprobes with activatable emission in the second near-infrared (NIR-II) window. (B) Fluorescence changes of NIR-II@Si (10 μM ZX-NIR) upon addition of 100 μM NaHS in PBS (pH 7.4). (C) Time-dependent NIR-II emission spectra. Inset: photograph of the H2S-activated NIR-II emission. (D) In vivo fluorescence imaging of mice bearing two different tumor types using H2S-activated NIR-II@Si nanoprobe. Reproduced from ref. 85. Copyright 2018 WILEY-VCH. |
In the last few years, people in related fields have been working on developing photoacoustic probes for detecting H2S in vivo. Shi et al.88 developed a H2S-activated Si@BODPA photoacoustic probe that encapsulates a semi-cyanine-BODIPY hybrid dye (BODPA) in the interior of a silica nanocomposite (Fig. 6A); thereby the probe has good water solubility and excellent biocompatibility. Conversion of BODPA to BOD-HS within the nanoparticles (NPs) by aromatic nucleophilic substitution in the presence of H2S results in high NIR absorption around 780 nm (Fig. 6B). Therefore, the Si@BODPA probe produces a strong photoacoustic signal output in the NIR region. The detection limit was measured to be 53 nM. The probe shows an extremely fast response and can detect transient changes in H2S. Si@BODPA allows direct photoacoustic tracking of endogenous H2S production in an HCT116 (human colon cancer cell) tumor-bearing mouse model. As shown in Fig. 6C, there was no photoacoustic signal from the normal sites of mice and the tumor site of the mice pre-treated with the CBS inhibitor aminooxyacetic acid (AOAA, 100 nmol) after injection of Si@BODPA, while a photoacoustic signal was observed in the tumors of the mice without and with pretreatment with a CBS activator (S-adenosyl-L-methionine), indicating that Si@BODPA can be used for detection of H2S in vivo.
Fig. 6 (A) Schematic illustration of the construction of activatable photoacoustic probes for H2S. (B) The absorption changes of Si@BODPAs (10 μM BODPA1 or BODPA2) in the absence and presence of NaHS (100 μM). (C) Photoacoustic imaging of tumor-bearing mice using Si@BODPA1 at different times: (1) saline-treated mice in the tumor regions; (2) probe-treated mice at normal sites; (3) probe-treated mice in the tumor regions; (4,5) mice pre-treated with (4) 100 nmol AOAA, or (5) 300 nmol S-adenosyl-L-methionine for 12 h, were subcutaneously injected with Si@BODPA in the tumor regions. Graph, photoacoustic intensities as a function of time post-injection of Si@BODPA. Reproduced from ref. 88. Copyright 2017 Royal Society of Chemistry. |
At present, photoacoustic probes for H2S detection mostly provide single-response photoacoustic signals, and the results will be affected by factors such as instrument, probe concentration and external environment. On the contrary, a ratiometric photoacoustic probe can eliminate the effects of the above factors by using the ratio of two separate wavelength photoacoustic response signals, thereby obtaining reliable experimental results. Ma et al.89 developed a novel ratiometric photoacoustic nanoprobe for in vivo detection of H2S. The nanoprobe AzHD-LP consists of a liposome (LP) with a H2S-responsive near-infrared dye (AzHD) encapsulated inside it (Fig. 7A). After the reduction of azide to amine in the AzHD-LP photoacoustic probe by H2S, the absorption peak appears red-shifted. The absorption of AzHD-LP at 600 nm is reduced, while the absorption at 700 nm is increased, resulting in a ratiometric PA signal in the presence of H2S. The detection limit of AzHD-LP for NaHS in solution was determined to be 91 nM. Furthermore, after AzHD-LP was conjugated to tumor-targeting peptide c(RGDyK), detection of intratumoral H2S production in HCT116 colon tumor mice was achieved under excitation of 532 nm and 700 nm pulsed lasers (Fig. 7B).
Fig. 7 (A) Illustration of the construction of activatable nanoprobe AzHD-LP and the proposed mechanism for ratiometric photoacoustic (PA) detection of H2S. (B) PA/ultrasound (US) overlaid images of subcutaneous HCT116 tumor in naked mice pretreated with RGD-AzHD-LP, and plot of ratiometric intensity (PA700/PA532) against time. Reproduced from ref. 89. Copyright 2018 Royal Society of Chemistry. |
In this section, fluorescent probes and photoacoustic (PA) probes for H2S detection are introduced. Although fluorescent probes are widely used in the detection of H2S, their applications in vivo are limited by the autofluorescence and penetration depth. Photoacoustic imaging with high tissue penetration can be used to detect H2S levels in the living body and accurately locate a lesion. However, their sensitivity impedes their further application. As a result, it is necessary to develop better probes. NIR-II fluorescence and NIR-II photoacoustic imaging90,91 are emerging technologies that exhibit greater penetration depth and higher sensitivity. Therefore, the design of NIR-II fluorescence probes with weaker autofluorescence and NIR-II PA probes is the way forward.
Therapeutic agent type | Therapeutic strategy | Tumor species | Ref. |
---|---|---|---|
Mesoporous silica nanoparticle (MANP-N3-FA) | Chemotherapy | Colon cancer | 94 |
N3-Nap-PHEMA-b-PMMA-N3 | Chemotherapy | Cervical cancer | 95 |
CuDOX NP | Chemotherapy | Cervical cancer | 96 |
[Cu2(ZnTcpp)·H2O]n | Photodynamic therapy | Colon cancer | 99 |
Electrochromic materials (EMs) | Photodynamic therapy | Colon cancer | 100 |
Theranostic prodrug (Nano-TNP-SO) | Photodynamic therapy | Colon cancer | 101 |
Self-assembled H2S response small molecule (SSS) | Photothermal therapy | Colon cancer | 103 |
Cu2O | Photothermal therapy | Colon cancer | 104 |
Fig. 8 (A) Surface functionalization on MSNPs and mobilization of DOX-loaded MSNP-N3-FA into HT-29 cells, and H2S-triggered drug release inside the cell. (B) Antitumor efficacy of DOX-loaded MANP-N3-FA in vivo. Reproduced from ref. 94. Copyright 2019 American Chemical Society. (C) Schematic illustration of how H2S triggers charge reversal and cellular uptake of N3-NapPHEMA45-b-PMMA42-N3 micelles. (D) Biodistribution of DOX in 4T1 tumor-bearing mice at 4 h post-injection. Data are presented as percentage of injected dose per gram (%ID per g). Reproduced from ref. 95. Copyright 2016 American Chemical Society. |
Similarly, Zhang et al.95 used a series of N-(2-hydroxyethyl)-4-azide-1,8-naphthalimide-ended amphiphilic diblock copolymer poly(2-hydroxyethyl methacrylate)-block-polymethylmethacrylate (N3-Nap-PHEMA-b-PMMA-N3) polymer nano-micelles for loading DOX (Fig. 8C). Under the action of H2S, the charge on the surface of the micelles of these nanomaterials is reversed and the azide reduction reaction occurs. The surface charge of the micelles changes from negative to positive, which promotes the uptake of the materials by the cells and accelerates the release of DOX (Fig. 8D).
A pharmaceutical carrier should have excellent biocompatibility. Chen et al.96 designed a H2S-activated protein cage (CuDOX NP) loaded with chemotherapeutic drugs. They used horse spleen apoferritin (apo-HSF) as a container for copper-complexed doxorubicin to obtain a water-soluble nanocomposite. Breaking of the CuDOX coordination interaction by H2S under physiological pH conditions allows the DOX to be slowly released from the protein cage without disrupting the structure of the protein. In vitro cell experiments showed that CuDOX nanoparticles activated by H2S can reduce the premature release of drugs, reduce the toxicity of DOX to normal cells, and enhance the anti-cancer effect.
Fig. 9 (A) The simple structural fragment of MOF NP-1 and the proposed strategy for 1O2 generation in cancer therapy. (B) Fluorescence spectra of NP-1 reaction with HS− from 0 to 70 μM. (C) In vivo antitumor efficacy of NP-1 on HCT116 subcutaneous xenograft nude mice. Reproduced from ref. 99. Copyright 2017 WILEY-VCH. (D) Schematic illustration of H2S-activatable 12+-PSs-FA enabling controllable 1O2 generation for PDT. (E) The tumor treatment effect of 12+-PSs-FA. Reproduced from ref. 100. Copyright 2018 American Chemical Society. |
In addition, Wu et al.100 reported a class of H2S-activated fluorescent probes and photodynamic smart reagents using electrochromic materials (EMs) with organic π-electron structure (dicationic 1,1,4,4-tetraphenylbutadiene, 12+) as H2S-responsive chromophores. EM12+ is doped into semiconductor polymer nanoparticles (SNPs) to form H2S-activatable fluorescent probes (12+-SNPs) (Fig. 9D). Within 12+-SNPs, EM12+ can effectively quench the fluorescence of SNP by a fluorescence resonance energy transfer (FRET) process. Subsequent reduction of 12+ to colorless 2 NPs by H2S eliminates the FRET process and restores fluorescence. Further, tumor-targeting ligand folic acid modified fluorescent probes (12+-SNP830-FA) were used for tumor imaging in H2S-enriched mice. Tumor-targeting and H2S-activatable PSs (12+-PSs-FA) using EM12+ were further developed by replacing the SNP with organic PS. 12+-PSs-FA accumulates well at the tumor site. After H2S-specific activation, 12+-PSs-FA produces ROS under the action of 808 nm laser irradiation. The reagent exhibits negligible phototoxicity to normal tissues and significant tumor photodynamic therapy effects (Fig. 9E).
In addition, Wang et al.101 have designed and synthesized a theranostic prodrug (TNP-SO) for H2S-activatable near-infrared emission-guided on-demand administration of PDT. The theranostic probe consists of an H2S-activated NIR imaging probe and a sensitizing drug. These two units are connected by a short diglycolamine spacer. The newly obtained small molecule probe is encapsulated into the hydrophobic interior of a silica nanocomposite to produce a nanoprobe with good water solubility and photostability. The absorption of TNP-SO at 509 nm decreased as 677 nm NIR absorption increased after being triggered by H2S. The NIR fluorescence increased linearly with H2S concentration (0–20 μM), and the determined detection limit was 21 nM, indicating that Nano-TNP-SO has high sensitivity for H2S detection. Nanoprobes can also act as good photosensitizers for the efficient production of 1O2. The in vivo results using this probe reveal that cancer imaging accurately guides the location of light exposure to produce the cytotoxic ROS required for on-demand cancer treatment, maximizing treatment efficiency and minimizing side effects.
Fig. 10 (A) Schematic diagram of photothermal activation for NIR-II fluorescence guidance treatment of colorectal cancer rich in H2S. (B) Infrared thermal images and heating effect in HCT116 tumor-bearing mice under continuous NIR laser irradiation and mean temperature as a function of irradiation time. (1) No administration of probes; (2) mice treated with probe at normal sites; (3) mice treated with probe in the tumor regions. (C) In vivo treatment results of photothermal therapy with Nano-PT. Reproduced from ref. 103. Copyright 2018 American Chemical Society. (D) Schematic diagram of Cu2O in situ reaction mechanism. (E) The temperature-increasing effect at the tumor site under laser irradiation (808 nm, 1 W cm−2). (F) In vivo photothermal therapy effect of Cu2O on HCT116 tumor. Reproduced from ref. 104. Copyright 2018 WILEY-VCH. |
An et al.104 designed an intelligent diagnostic reagent for colon cancer based on the in situ reaction of cuprous oxide (Cu2O) with endogenous H2S at the colon tumor site (Fig. 10D). Highly expressed endogenous H2S in colon tumors reacts with cuprous oxide and produces copper sulfide, which has strong near-infrared absorption, triggering photoacoustic and photothermal effects (Fig. 10E). The design of the in situ reaction at the tumor site reduces the damage to normal tissues during treatment and produces a significant therapeutic effect (Fig. 10F).
We believe that the integration of diagnostic and therapeutic agents for H2S detection and related disease treatment has a broad development prospect. In our subsequent research we aim to: (i) develop diagnostic reagents that are easy to prepare, and have good stability and biocompatibility; (ii) combine a variety of methods for tumor diagnosis and treatment, to develop intelligent diagnostic reagents with multi-modal diagnosis and synergistic treatment—for example, combining fluorescent probes with photoacoustic probes;105 (iii) undertake an in-depth study of the side effects of various agents, as well as their potential toxicity. Only once the problems described in this review have been solved, can the reagents can be further applied to clinical use.
This journal is © The Royal Society of Chemistry 2019 |